Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, et al. European heath systems and cancer care. Ann Oncol 2003; 14: 41–60.
Mohaghegh FA, Hamta A, Shariat Zade SA. [Investigation of current cancers in Markazi province and its registration system in 2001-2006 in compare with country statistics]. Journal of Arak University of Medical Sciences 2008; 11: 84–94.
Akbari ME, Naghavi M. [Economical burden of cancers in Iran]. Daroo and darman Journal 2009; 67: 51–6.
Hatam N, Ahmadloo N, Ahmad Kia Daliri A, Bastani P, Askarian M. Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-ﬂuorouracil). Arch Gynecol Obstet
2011; 284: 215–20. doi: 10.1007/s00404-010-1609-8
Yen JY, Ko CH, Yen CF, Yang MJ, Wu CY, Juan CH, et al.
Quality of life, depression, and stress in breast cancer women outpatients receiving active therapy in Taiwan. Psychiatry Clin Neurosci 2006; 60: 147–53. doi: 10.1111/j.1440-1819.2006.01479.x
Bland KI, Sarr MG, Buchler MW, Csendes A, Garden OJ, Wong J. General Surgery: Principles and International Practice. Australia: Springer; 2010.
Phipps WJ, Long BC, Woods N. Medical-surgical nursing: concepts and clinical practice. 5th ed. St. Louis, MO: Mosby; 1995.
Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, et al
. Breast Cancer in Iran: an epidemiological review. Breast J
2007; 13; 383–91. doi: 10.1111/j.1524-4741.2007.00446.x
Gholikhani R, Sadrmomtaz N. [Health cost analysis]. 1st ed. Tehran: Debizesh publication; 2001.
Nouroozi T, Salehi A. Prime costs of clinical laboratory services in Tehran Valiasr Hospital in 2009. EMHJ 2013; 19: 159–65.
Hatam N, Bastani P, Ahmadloo N, Kiadaliri AA. Health Related Quality of Life in Breast Cancer Patients Undergoing Current Chemotherapy Protocols. Kerman University of Medical Sciences Journal 2011; 19: 37–46.
Phipps WJ, Long BC, Woods N. Medical-surgical nursing. 7th ed. St. Louis, MO: Mosby; 2003.
Andersen R, Hager M. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities. Health Educ Behav
2002; 29: 755-70. doi: 10.1177/109019802237942
Risenquist J, Lindfors K. Screening mammography in women aged 40-49 years: analysis if cost-effectiveness. Radiology 1994; 191: 647–50.
Lebovic GS, Hollingsworth A, Feig SA. Risk assessment, screening and prevention of breast cancer: A look at cost-effectiveness. Breast
2010; 19: 260–7. doi: 10.1016/j.breast.2010.03.013
Pisati G, Cerri S, Marinelli M, Tedeschi B, Valsecchi E. [Cancer screening programme in health care workers]. G Ital Med Lav Ergon 2011; 33: 57–60.
Hadi N, Sadeghi-Hassanabadi A, Talei AR, Arasteh MM, Kazerooni T. Assessment of a breast cancer screening programme in Shiraz, Islamic Republic of Iran. East Mediterr Health J 2002; 8: 386–92.
Grann VR, Patel PR, Jacobson JS, Warner E, Heitjan DF, Ashby-Thompson M, et al.
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat
2011; 125: 837–47. doi: 10.1007/s10549-010-1043-4
Smith RA. Cancer screening in the USA. J Med Screen 2006; 13: 48–53.
Mehrabani D, Tabei SZ, Heydari ST, Shamsina SJ, Shokrpour N, Amini M, et al. Cancer Occurrence in Fars Province, Southern Iran. Iran Red Crescent Med J 2008; 10: 314–22.
Schousboe JT, Kerlikowske K, Loh A, Cummings SR. Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness. Ann Intern Med
2011; 155: 10–20. doi: 10.7326/0003-4819-155-1-201107050-00003
Boer R, de Koning H, Threlfall A, Warmerdam P, Street A, Friedman E, et al
. Cost effectiveness of shortening screening interval in extending age range of NHS breast screening programme: computer simulation study. BMJ
1998; 317: 376-9. doi: 10.1136/bmj.317.7155.376
Stout NK, Rosenberg MA, Trentham-Dietz A, Smith MA, Robinson SM, Fryback DG. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst
2006; 98: 774–82. doi: 10.1093/jnci/djj210
Peregrino AA, Vianna CM, de Almeida CE, Gonzáles GB, Machado SC, Costa e Silva FV, et al. [Analysis of Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance imaging]. Cien Saude Colet 2012; 17: 215–22.
Verbeek AL, van Dijck JA, Kiemeney LA, Broeders MJ. Responsible cancer screening. Ned Tijdschr Geneeskd 2011; 155: A3934.